| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Director | Common Stock | 93.4K | $3.59M | $38.47 | Jun 20, 2024 | Direct |
| GILEAD SCIENCES, INC. | Director | Restricted Stock Unit | 7.8K | $509K | $65.27 | May 8, 2024 | Direct |
| Moderna, Inc. | Director | Restricted Stock Units | 979 | $111K | $113.40 | May 6, 2024 | Direct |
| Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct | ||
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 12.6K | May 8, 2024 | Direct | ||
| Revolution Medicines, Inc. | Director | Earn-out Shares | 10.7K | Nov 9, 2023 | Direct | ||
| Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 10.2K | Jun 20, 2024 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 5.67K | May 6, 2024 | Direct | ||
| EQRx, Inc. | Director | Common Stock | 0 | $2.21 | Nov 9, 2023 | Direct | |
| EQRx, Inc. | Director | Earn-out Shares | 0 | Nov 9, 2023 | Direct | ||
| EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 9, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | Jun 20, 2024 | 2 | $0 | 4/A | Jun 28, 2024 | Director |
| RVMD | Revolution Medicines, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| GILD | GILEAD SCIENCES, INC. | May 8, 2024 | 2 | $0 | 4 | May 9, 2024 | Director |
| MRNA | Moderna, Inc. | May 6, 2024 | 2 | $0 | 4 | May 7, 2024 | Director |
| RVMD | Revolution Medicines, Inc. | Nov 9, 2023 | 5 | $0 | 4 | Nov 14, 2023 | Director |
| RVMD | Revolution Medicines, Inc. | Nov 9, 2023 | 0 | $0 | 3 | Nov 14, 2023 | Director |
| EQRX | EQRx, Inc. | Nov 9, 2023 | 4 | $0 | 4 | Nov 9, 2023 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
| MRNA | Moderna, Inc. | May 3, 2023 | 1 | $0 | 4 | May 5, 2023 | Director |
| GILD | GILEAD SCIENCES, INC. | May 3, 2023 | 2 | $808K | 4 | May 4, 2023 | Director |
| MRNA | Moderna, Inc. | Apr 28, 2023 | 2 | $0 | 4 | May 1, 2023 | Director |
| EQRX | EQRx, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| EQRX | EQRx, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4/A | Jun 27, 2022 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| GILD | GILEAD SCIENCES, INC. | May 5, 2022 | 2 | $972K | 4 | May 6, 2022 | Director |
| GILD | GILEAD SCIENCES, INC. | May 3, 2022 | 2 | $0 | 4 | May 3, 2022 | Director |
| MRNA | Moderna, Inc. | Apr 28, 2022 | 4 | $0 | 4 | May 2, 2022 | Director |
| EQRX | EQRx, Inc. | Dec 17, 2021 | 3 | $0 | 4 | Dec 21, 2021 | Director |
| EQRX | EQRx, Inc. | Dec 17, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| GILD | GILEAD SCIENCES INC | May 12, 2021 | 2 | $0 | 4 | May 14, 2021 | Director |